NCT03912025

Brief Summary

A cross sectional study utilizing congenital heart disease patients presenting for clinically indicated cardiopulmonary exercise test. Baseline questionnaires (see below) will be administered prior to the exercise test. Exercise test data and clinical data will be recorded. Questionnaire data will be compared to clinical data in and between disease severity groups. Disease severity will be determined based on hemodynamic (not anatomic) classification according to an algorithm adapted from the European Society of Cardiology.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 10, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 11, 2019

Completed
10 months until next milestone

Study Start

First participant enrolled

January 30, 2020

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 12, 2021

Completed
13 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 25, 2021

Completed
Last Updated

August 4, 2021

Status Verified

April 1, 2021

Enrollment Period

1.2 years

First QC Date

April 10, 2019

Last Update Submit

August 3, 2021

Conditions

Outcome Measures

Primary Outcomes (3)

  • Patient Reported Outcomes Measurement Information System (PROMIS) Pediatric Meaning and Purpose Score

    A series of 8 questions that ask about future hopes, created and validated by a branch of the National Institutes of Health (www.healthmeasures.net). The final score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation (SD) of 10. A higher PROMIS T-score represents more of the concept being measured. For positively-worded concepts like Meaning and Purpose, a T-score of 60 is one SD better than average. By comparison, a Meaning and Purpose T-score of 40 is one SD worse than average.

    up to 60 minutes

  • Patient Reported Outcomes Measurement Information System Pediatric Anxiety Score

    A series of 8 questions to assess the degree of anxiety felt in the past week, created and validated by a branch of the National Institutes of Health (www.healthmeasures.net). The final score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation (SD) of 10. For negatively-worded concepts like anxiety, a T-score of 60 is one SD worse than average. By comparison, an anxiety T-score of 40 is one SD better than average.

    up to 60 minutes

  • Ratio of Meaning and Purpose Score to Anxiety Score

    Since positive mindset is represented by a high score on the Meaning and Purpose scale, and a low score on the Anxiety scale, patients with high ratios (greater than 1) will have the most positive mindsets, while those with low ratios (less than 1) will have the least positive mindsets.

    up to 60 minutes

Secondary Outcomes (4)

  • Patient Reported Outcomes Measurement Information System Physical Activity Questionnaire

    up to 60 minutes

  • Patient Reported Outcomes Measurement Information System Pediatric Life Satisfaction Score

    up to 60 minutes

  • Patient Reported Outcomes Measurement Information System Pediatric Positive Affect/Well Being Score

    up to 60 minutes

  • Pediatric Cardiac Quality of Life Inventory Questionnaire (PCQLI)

    up to 60 minutes

Study Arms (2)

Mild hemodynamic CHD

"Mild" severity category will be defined in terms of hemodynamic parameters rather than anatomic diagnoses, as outlined in the European Society of Cardiology Section on Sports Cardiology consensus guidelines (Budts W, Borjesson M, Chessa M, van Buuren F, Trindade PT, Corrado D, Heidbuchel H, Web G, Holm J, Papadakis M. 2013). They define functional parameters such as systolic function, oxygen saturation, rhythm disorders, elevated pressure or volume load, etc. to divide patients into 3 hemodynamic groups. Based on their model, we define "mild CHD" as ones falling into the group that can train at "High Intensity" exercise levels.

Other: Relationship between positive mindset and exercise capacity

Moderate hemodynamic CHD

"Moderate" severity category will be defined in terms of hemodynamic parameters rather than anatomic diagnoses. Based on their model, we define "moderate CHD" as those that can train at "Moderate Intensity."

Other: Relationship between positive mindset and exercise capacity

Interventions

No intervention. Cross-sectional study looking at the relationships between questionnaire scores and outcomes

Mild hemodynamic CHDModerate hemodynamic CHD

Eligibility Criteria

Age8 Years - 17 Years
Sexall
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Congenital Heart disease Patients

You may qualify if:

  • Patients age 8-17 with congenital heart disease
  • Classified as mild or moderate hemodynamic severity
  • Presenting to outpatient department for clinically indicated cardiopulmonary exercise test

You may not qualify if:

  • Patients on beta blockers or negative inotropes
  • Patients with pacemakers/ICDs
  • Patients with active arrhythmias
  • Patients with significant musculoskeletal or pulmonary disease
  • Patients unable to complete a maximal exercise test or for whom an exercise test is contraindicated
  • Patients who are not fluent in English
  • Patients unable to complete the questionnaire
  • Patients who have severely hemodynamic debilitation or at risk (severe systolic dysfunction, severe ventricular hypertrophy, severe pressure load, severe volume load, severe pulmonary hypertension, malignant arrhythmia, significant central cyanosis)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Boston Children's Hospital

Boston, Massachusetts, 02115, United States

Location

MeSH Terms

Conditions

Heart Defects, Congenital

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Naomi Gauthier, MD

    Boston Children's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pediatric Cardiologist

Study Record Dates

First Submitted

April 10, 2019

First Posted

April 11, 2019

Study Start

January 30, 2020

Primary Completion

April 12, 2021

Study Completion

April 25, 2021

Last Updated

August 4, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations